47 related articles for article (PubMed ID: 38545258)
21. miR‑135a‑5p inhibits tumor invasion by targeting ANGPT2 in gallbladder cancer.
Diao H; Xu X; Zhao B; Yang G
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036386
[TBL] [Abstract][Full Text] [Related]
22. The LncRNA FGD5-AS1/miR-497-5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin-resistance in laryngeal squamous cell carcinoma.
Song K; Yu P; Zhang C; Yuan Z; Zhang H
Mol Carcinog; 2021 Jul; 60(7):469-480. PubMed ID: 34003510
[TBL] [Abstract][Full Text] [Related]
23. miRNA interplay: mechanisms and consequences in cancer.
Hill M; Tran N
Dis Model Mech; 2021 Apr; 14(4):. PubMed ID: 33973623
[TBL] [Abstract][Full Text] [Related]
24. LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.
Jing Z; Guo S; Zhang P; Liang Z
Technol Cancer Res Treat; 2020; 19():1533033820985787. PubMed ID: 33371795
[TBL] [Abstract][Full Text] [Related]
25. The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential.
Pandya G; Kirtonia A; Sethi G; Pandey AK; Garg M
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188423. PubMed ID: 32871244
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-29a functions as a tumor suppressor through targeting STAT3 in laryngeal squamous cell carcinoma.
Liu YB; Wang Y; Zhang MD; Yue W; Sun CN
Exp Mol Pathol; 2020 Oct; 116():104521. PubMed ID: 32858006
[TBL] [Abstract][Full Text] [Related]
27. lncRNA IGKJ2-MALLP2 suppresses LSCC proliferation, migration, invasion, and angiogenesis by sponging miR-1911-3p/p21.
Cao J; Yang Z; An R; Zhang J; Zhao R; Li W; Xu L; Sun Y; Liu M; Tian L
Cancer Sci; 2020 Sep; 111(9):3245-3257. PubMed ID: 32639636
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma.
Nicolau-Neto P; de Souza-Santos PT; Severo Ramundo M; Valverde P; Martins I; Santos IC; Dias F; de Almeida Simão T; Ribeiro Pinto LF
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32085563
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
30. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
Li Y; Xu J; Guo YN; Yang BB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
[TBL] [Abstract][Full Text] [Related]
31. DIAPH2 alterations increase cellular motility and may contribute to the metastatic potential of laryngeal squamous cell carcinoma.
Kostrzewska-Poczekaj M; Byzia E; Soloch N; Jarmuz-Szymczak M; Janiszewska J; Kowal E; Paczkowska J; Kiwerska K; Wierzbicka M; Bartochowska A; Ustaszewski A; Greczka G; Grenman R; Szyfter K; Giefing M
Carcinogenesis; 2019 Oct; 40(10):1251-1259. PubMed ID: 30793164
[TBL] [Abstract][Full Text] [Related]
32. MiRNA-mRNA crosstalk in laryngeal squamous cell carcinoma based on the TCGA database.
Huang GJ; Luo MS; Chen GP; Fu MY
Eur Arch Otorhinolaryngol; 2018 Mar; 275(3):751-759. PubMed ID: 29332170
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-125b targeted STAT3 to inhibit laryngeal squamous cell carcinoma cell growth and motility.
Feng J; Fan Y; Ayiheng Q; Zhang H; Yong J; Hu B
Oncol Lett; 2017 Jul; 14(1):480-486. PubMed ID: 28693195
[TBL] [Abstract][Full Text] [Related]
34. An update on larynx cancer.
Steuer CE; El-Deiry M; Parks JR; Higgins KA; Saba NF
CA Cancer J Clin; 2017 Jan; 67(1):31-50. PubMed ID: 27898173
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-21 in laryngeal squamous cell carcinoma: Diagnostic and prognostic features.
Erkul E; Yilmaz I; Gungor A; Kurt O; Babayigit MA
Laryngoscope; 2017 Feb; 127(2):E62-E66. PubMed ID: 27545281
[TBL] [Abstract][Full Text] [Related]
36. miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1.
Zhang C; Chen X; Chen X; Wang X; Ji A; Jiang L; Sang F; Li F
Onco Targets Ther; 2016; 9():3555-63. PubMed ID: 27366092
[TBL] [Abstract][Full Text] [Related]
37. Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.
Yang LY; He CY; Chen XH; Su LP; Liu BY; Zhang H
Oncotarget; 2016 Jul; 7(30):48346-48359. PubMed ID: 27356739
[TBL] [Abstract][Full Text] [Related]
38. miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.
Tribollet V; Barenton B; Kroiss A; Vincent S; Zhang L; Forcet C; Cerutti C; Périan S; Allioli N; Samarut J; Vanacker JM
PLoS One; 2016; 11(5):e0156445. PubMed ID: 27227989
[TBL] [Abstract][Full Text] [Related]
39. New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
Cybula M; Wieteska Ƚ; Józefowicz-Korczyńska M; Karbownik MS; Grzelczyk WL; Szemraj J
Cancer Biomark; 2016; 16(4):559-68. PubMed ID: 27002759
[TBL] [Abstract][Full Text] [Related]
40. MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells.
Ren JW; Li ZJ; Tu C
Int J Clin Exp Pathol; 2015; 8(6):6356-66. PubMed ID: 26261511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
